- Company Announcement Date:
- FDA Publish Date:
- Product Type:
- Reason for Announcement:
Recall Reason Description
- Company Name:
- Teligent Pharma, Inc.
- Brand Name:
Teligent Pharma, Inc.
- Product Description:
Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL)
Buena, NJ, Teligent Pharma, Inc. is voluntarily recalling the five lots of Lidocaine HCl Topical Solution 4%, 50ml in a screw cap glass bottle listed in the table below to the user level. The product is being recalled because the firms testing has found it to be super potent based on an Out of Specification (OOS) result obtained at the 18-month stability timepoint.
|Lidocaine Hydrochloride Topical|
Solution USP 4% (40 mg/mL), 50
The product is indicated for the production of topical anesthesia of accessible mucous membranes of the oral and nasal cavities and proximal portions of the digestive tract and is packaged in a 50ml glass bottle with a screw cap with the identification NDC# 52565-009-50 and 63739-997-64. The product can be identified by the following labeling: Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL). Product was distributed at the wholesale and retail distribution levels in the US and Canada.
Teligent Pharma, Inc. is notifying its distributors via Fed-Ex and is arranging for return of all recalled products.
Consumers and patients that have Lidocaine HCl Topical Solution 4% which is being recalled are asked to discontinue use and dispose of the product immediately.
Consumers can call 1-856.697.1441 press * to reach the medical information call center Monday through Friday, 8am – 5pm or send an e-mail to [email protected] for any product or recall related questions for Lot #13262 Exp. 03/2022, Lot #14217 Exp. 08/2022, Lot #13058 Exp. 02/2022, Lot #13768 Exp. 05/2022, Lot #16306 Exp. 01/2024.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online
- Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Company Contact Information
Go to Source